Changing Practice Session (75-90 minutes)
Changing Practice Sessions aim to take a critical review of the trials presented in the plenary sessions, clinical symposia and proffered paper sessions. Experts from different disciplines shall give an overview of the implications for practice. In addition, one top-expert will question and define the value of these new treatments in the multidisciplinary context. The session will also host a roundtable discussion with a panel and audience interaction and voting.
Clinical Symposium (60 minutes)
A Scientific Symposium is focused on a topic/theme followed all the way through. In each Clinical Symposium, four speakers present key practice-changing trials and real world data. Following each 10-minute presentation, the chairs of the session facilitate a 5-minute Q&A period between the speaker and the audience.
Critical Review (90 minutes)
These sessions discuss the organisation of cancer services for the future, health economics of the cancer treatment and methodologies for outcome research.
ECCO Session (90 minutes)
This session focuses on the project on essential requirements for quality cancer care (ERQCC), which aims to defining organisational criteria on how to deliver optimal care to each patient and for quality performance indicators (QPI) that can help to measure the efficacy of the clinical guidelines. The session will focus 2 tumour types: colorectal cancer (CRC) and sarcoma.
Educational Immersion Programme (90-150 minutes)
The Educational Immersion Programme courses are aimed at audiences with either novice or advanced knowledge, giving in-depth education on two hot topics. Participants can follow both novice and advanced level sessions to get high immersion into the topic.
Educational Session (60-120 minutes)
Educational Sessions aim to explore topics that impact on daily practice and give knowledge on health economics and outcome research and that will best serve the educational needs of attendees.
Hot Debate (75 minutes)
The Hot Debate should follow an Oxford style format. In this debate format, a controversial topic is introduced, after which one speaker proposes the resolution, supported by a seconder, another individual opposes the motion, again supported by a seconder. All four speakers are invited to take on a devil's advocate role that will guarantee a scientifically lively session. The moderator of the debate session is responsible for liaising and preparing the arguments with the speakers. At the end of the session, the audience takes an informal vote.
Joint Session (75 minutes)
Joint sessions are scientific sessions focused on a topic or theme, organised jointly with other organisations, such as JSCO and ASCO.
Multidisciplinary Tumour Board Session (60 minutes)
Multidisciplinary Tumour Board sessions are interactive sessions addressing topical subjects comprising a moderator and expert panel representing various disciplines. The goal of the session is to understand how Multidisciplinary Tumour Boards work and provide an educational exercise.
The moderator of the session proposes one or two common cases which are shared in advance with the panel experts, in order to allow them to prepare for the discussion from their point of view. The moderator and panel experts then ensure a harmonised and lively session with interaction from the audience.
Patient Advocacy Session (60-90 minutes)
Programme developed by the ECCO Patient Advisory Committee (ECCO PAC) presenting and discussing topical issues for patients and survivors where all Congress delegates can learn what matters to patients.
Plenary Session (60 minutes)
During the Plenary Sessions, the newest and late-breaking practice-changing data is presented and discussed. Presentations cover a comprehensive range of topics across the four pillars of the programme: multidisciplinarity, outcome research, health economics of cancer care and the organisation of cancer care delivery.
Policy Session (90 minutes)
The Policy Sessions will be covering areas where EU developments on the one hand and the scientific, practitioner- and patient-driven cancer agenda on the other hand make multi-stakeholder dialogue policy particularly important. Several key themes will be addressed including the critical role of multidisciplinary workforce in cancer care, initiatives to support improvement in the quality of cancer care and the growing importance of the EU level as a collaborative playing field in cancer care. The latter aspect will be explored more in depth in light of the European Reference Networks (ERNs) and their potential for the organisation and delivery of cancer care in Europe.
Presentations in poster format of selected abstracts based on the four pillars of the programme.
Poster Discussion Session (50 minutes)
During a Poster Discussion Session, 7 poster presenters are invited to present their poster for a duration of 5 minutes each. At the end of the 7 presentations, the moderator of the session facilitates a 15-minute joint discussion between the presenters and the audience.
Poster Discussion Sessions are held in the poster area, with a large plasma screen placed in the middle of the posters.
Poster Spotlight Session (50 minutes)
During a Poster Spotlight Session, 5 poster presenters are invited to present their poster (the poster is displayed on the screen) for a duration of 5 minutes. Following each presentation, the moderator of the session will facilitate a 5-minute Q&A period to encourage a challenging discussion between the presenter and the audience.
Poster Spotlight Sessions take place in a dedicated area with a screen in the Poster Area.
Primary Care Session (60-90 minutes)
The primary care sessions will discuss the expanding and vital role of primary care at all stages of the cancer journey and the potential in developing new models of cancer control with greater primary care involvement and improved collaboration between primary care and secondary care. A ‘multidisciplinary’ approach of primary care involves a wide range of primary care professions like general practitioners, community nurses, community pharmacists, psycho-oncologists, physiotherapists, occupational therapists, informal carers, etc.
Proffered Paper Session (75-105 minutes)
Proffered Paper Sessions are composed of oral presentations of the top best and new late breaking abstracts. These sessions may include invited abstracts on key practicing changing data and outcome research.
During a Proffered Paper Session, presenters are invited to present their abstract for a duration of 10 minutes. Following each presentation, the chairpersons will facilitate a 5-minute Q&A period to encourage interaction between the presenter and the audience.
Regulatory Session (75 minutes)
Regulatory sessions are interactive sessions discussing the regulatory process and issues for clinical trials. The sessions bring together European Regulatory bodies, HTAs, industry, patient advocates and oncologists to discuss issues in target therapies.
ECCO member societies are invited to host a meeting on a topic of their choice for their members. These are half or one day programmes that take place on Friday 27 January
Workshop (90 minutes)
The workshop is an educational interactive session enabling the participant to use the topics that are discussed in the daily work life.
PRINT THIS PAGE
Page last modified: